Researcher
Samir Kumar-Singh
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Infectious diseases, Anatomical pathology, Neurological and neuromuscular diseases, Clinical genetics and molecular diagnostics
Affiliations
- Laboratory of Medical Microbiology (LMM) (Research group)
Member
From1 Jan 2019 → Today - Laboratory of cell biology and histology (Research group)
Member
From1 Oct 2011 → Today - Translational Neurosciences (TNW) (Research group)
Member
From1 Oct 2011 → Today - Vaccine & Infectious Disease Institute (VAXINFECTIO) (Research group)
Member
From1 Oct 2011 → 31 Dec 2018 - Department of Biomedical Sciences - other (Research group)
Member
From1 Mar 2010 → 30 Sep 2011 - VIB CMN - Neurodegenerative Brain Diseases Group (Research group)
Member
From1 Oct 2003 → 28 Feb 2010
Projects
1 - 10 of 30
- Fecal microbiotal transplantation as a method for improving the outcomes of the dual radio- and immunotherapies within a colorectal cancer mouse model.From1 Oct 2022 → TodayFunding: SCK (Study Centre Nuclear Energy)
- Advanced Centre for Advanced Microscopy (ACAM).From1 Jan 2022 → TodayFunding: BOF - research organisations
- IMARK. Network for image-based biomarker discovery and evaluationFrom1 Jan 2021 → TodayFunding: IOF - mandates
- Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic (ORCHESTRA).From1 Dec 2020 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic (ORCHESTRA).From1 Dec 2020 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Molecular insights in SARS-CoV-2 pathogenesis and epidemiology.From1 Jun 2020 → 31 May 2021Funding: BOF - projects
- High-resolution slide scanner for digital histopathological phenotyping in health and disease.From1 Jan 2020 → 31 Dec 2021Funding: BOF - scientific equipment program
- Multidimensional analysis of the nervous system in health and disease (µNeuro).From1 Jan 2020 → TodayFunding: BOF - research organisations, Fund Recuperation Fiscal Exemption
- The impact of mixed or polymicrobial flora in the development of ventilator-associated pneumonia.From1 Oct 2019 → 31 May 2022Funding: BOF - doctoral mandates
- The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use (VALUE-Dx).From1 Apr 2019 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing, Foreign industrial entreprises
Publications
21 - 30 of 82
- Identification of potential urinary metabolite biomarkers of Pseudomonas aeruginosa ventilator-associated pneumonia(2022)
Authors: Bart 's Jongers, An Hotterbeekx, Kenny Bielen, Philippe Vervliet, Jan Boddaert, Erik Fransen, Geert Baggerman, Adrian Covaci, Herman Goossens, Surbhi Malhotra, et al.
Pages: 1 - 11 - No evidence for the involvement of leiomodin-1 antibodies in the pathogenesis of onchocerciasis-associated epilepsy(2021)
Authors: An Hotterbeekx, Krizia Vieri, Melanie Ramberger, Ashraf Jozefzoon-Aghai, Michel Mandro, Floribert Tepage, Alfred Dusabimana, Samir Kumar-Singh, Maarten J. Titulaer, Robert Colebunders
- The secretome of filarial nematodes and its role in host-parasite interactions and pathogenicity in onchocerciasis-associated epilepsy(2021)
Authors: Jolien Perneel, Krizia Vieri, Samir Kumar-Singh
- Assessing the impact of flavophospholipol and virginiamycin supplementation on the broiler microbiota(2021)
Authors: Mohamed Mysara Ahmed, Matilda Berkell, Basil Britto Xavier, Sarah De Backer, Veerle Hautekiet, Spas Petkov, Herman Goossens, Samir Kumar-Singh, Surbhi Malhotra
- A dynamic mucin mRNA signature associates with COVID-19 disease presentation and severity(2021)
Authors: Annemieke Smet, Tom Breugelmans, Johan Michiels, Kevin Lamote, Wout Arras, Joris De Man, Leo Heyndrickx, Anne Hauner, Manon Huizing, Surbhi Malhotra, et al.
- Neuropathological changes in Nakalanga syndrome(2021)
Authors: An Hotterbeekx, Martin Lammens, Sylvester Onzivua, Robert Lukande, Francis Olwa, Samir Kumar-Singh, Stijn Van Hees, Richard Idro, Robert Colebunders
- Serotonin levels in the serum of persons with onchocerciasis-associated epilepsy(2021)
Authors: Krizia Vieri, An Hotterbeekx, Michel Mandro, Joseph Nelson Siewe Fodjo, Alfred Dusabimana, Francoise Nyisi, Deby Mukendi, Joe Gwatsvaira, Samir Kumar-Singh, Robert Colebunders
- Cytokines and onchocerciasis-associated epilepsy, a pilot study and review of the literature(2021)
Authors: Krizia Vieri, Stephen Raimon, Gasim Abd-Elfarag, Deby Mukendi, Jane Y. Carter, Samir Kumar-Singh
- Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection(2021)
Authors: Rachel Wheatley, Julio Diaz Caballero, Natalia Kapel, Fien De Winter, Pramod Jangir, Angus Quinn, Ester del Barrio-Tofino, Carla Lopez-Causape, Jessica Hedge, Gabriel Torrens, et al.
Pages: 1 - 12 - Evaluation of GeneXpert PA assay compared to genomic and (semi-)quantitative culture methods for direct detection of Pseudomonas aeruginosa in endotracheal aspirates(2021)
Authors: Thomas van der Schalk, Jasmine Coppens, Leen Timbermont, Agata Turlej-Rogacka, Liesbet Van Heirstraeten, Matilda Berkell, Li Yu, Basil Britto Xavier, Veerle Matheeussen, Margareta Ieven, et al.
Patents
1 - 5 of 5
- Identification of subjects at risk of developing ventilator-associated pneumonia (Inventor)
- Identification of subjects at risk of developing ventilator-associated pneumonia (Inventor)
- Detecting and treating dementia (Inventor)
- Detecting and treating dementia (Inventor)
- Detecting and treating dementia (Inventor)